Bayer's Spanish Aspirin Plant Decarbonization: 6,500 Tonnes CO2 Cut at Langreo Facility
ad-hoc-news.deBayer's pharmaceutical production site in Langreo, Spain, is being converted into what the company says will be the first fully decarbonized active-ingredient plant in the country. The EUR 17 million project, recognized with an award from Iberdrola, targets near-zero process emissions for Aspirin production and is expected to avoid more than 6,500 tonnes of CO2 per year. The new energy system is in test operation, with regular service planned before the end of 2026. The announcement comes during a mixed week for Bayer. A Delaware court rejected early dismissal motions in mRNA patent lawsuits, while a separate Roundup trial opened in Missouri. The stock fell more than 5 percent after JPMorgan flagged consensus estimates as too high. For anyone tracking industrial decarbonization, the Langreo project is a concrete example of a large manufacturer retrofitting an existing site rather than waiting for new regulation. The key detail to watch is whether the facility actually reaches full service on schedule and what technology mix gets it there.
